12. Congenital myasthenic syndrome Disease details / Clinical trials / Drug dev / DR info


Clinical trials : 5 Drugs : 7 - (DrugBank : 3) / Drug target genes : 5 - Drug target pathways : 13

Drugs and their primary sponsors and trial info
3,4-DIAMINOPYRIDINE   
   Lahey Clinic
      2001   -   NCT00872950   United States;
3,4-Diaminopyridine   
   Ricardo Maselli
      2018   -   NCT03062631   United States;
3,4-diaminopyridine   
   Vern C. Juel, M.D.
      2013   -   NCT01765140   United States;
Albuterol   
   Mayo Clinic
      2010   Phase 1   NCT01203592   United States;
Amifampridine Phosphate   
   Catalyst Pharmaceuticals, Inc.
      2014   -   NCT02189720   United States;